Discussing expensive Anti-cancer drugs

British Journal of Health Care Management

Volumn 17, Issue 5, 2011, Pages 206-212

  Fallowfield, Lesley ^a   Solis Trapala, Ivonne ^b   Jones, Alison ^c   Barrett, Jane ^d   Langridge, Carolyn ^a   Jenkins, Valerie ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL COLLEGE OF RADIOLOGISTS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79956063635     PISSN: 13580574     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjhc.2011.17.5.206     Document Type: Article

References (15)

1. Berry SR, Bell CM, Ubel PA et al (2010) Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. J Clin Oncol 28(27): 4149-4153
2. Cox A, Jenkins V, Catt S et al. (2006) Information needs and experiences: an audit of UK cancer patients. Eur J Oncol Nurs 10(4): 263-272 (Pubitemid 44340659)
3. Hack TF, Pickles T, Ruether JD et al (2010) Predictors ofdistress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role. Psychooncology 19(6): 606-16
4. Jefford M, Mileshkin L, Schofield P et al (2009) Discussing expensive anticancer drugs. J Clin Oncol. 27(3): 476-477
5. Jenkins V, Fallowfield L, Saul J (2001) Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 84(1): 48-51 (Pubitemid 32102503)
6. Kaser E, Shaw J, Marven M et al (2010) Communication about high-cost drugs in oncology-the patient view. Ann Oncol 21(9): 191-194
7. Martin D, Gishin C (2008) Victim of a broken promise: Mother, 37, forced to sell her home to buy cancer drugs Labour pledged to fund in Daily Mail. Available at: http://www.dailymail.co.uk/news/election/article-1264680/Cancer- row-mother-37-forced-sell-home-buy-drugs-Labour-pledged-fund.html#ixzz12RNXxxm8 (accessed 27 April 2011)
8. Mileshkin L, Schofield PE, Jefford M et al (2009) To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment option. J Clin Oncol 1:27(34): 5830-5837.
9. NICE (2010) Measuring effectiveness and cost effectiveness: the QALY. Available at: http://www.nice.org.uk/newsroom/features/ measuringeffectivenessandcosteffectivenesstheqaly.jsp (accessed 28 April 2011).
10. NICE (2010) NICE and cancer drugs-the facts. Available at: http://www.nice.org.uk/newsroom/factsheets/niceandcancerdrugsthefacts.jsp (accessed 28 April 2011).
11. Ramirez AJ, Graham J, Richards MA et al (1996) Mental health of hospital consultants: the effects of stress and satisfaction at work. Lancet 16:347(9003): 724-728 (Pubitemid 26085647)
12. Ramirez AJ, Graham J, Richards MA et al (1996) Stress at work for the clinical oncologist. Clin Oncol (R Coll Radiol) 8(3): 137-139
13. Richards M (2008) Improving access to medicines for NHS patients: a report for the Secretary of State for Health. Available at: http://www.dh.gov. uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/ DH-089927 (accessed 28 April 2011)
14. Schrag D, Hanger M (2007) Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey. J Clin Oncol 10:25(2): 233-237. (Pubitemid 350003040)
15. Waxman J (2008) Arrogant, illogical and totally out of touch, NICE must be scrapped⋯it's killing too many people. Daily Mail. Available at: http://www.dailymail.co.uk/news/article-1043688/Arrogantillogical-totally-touch- NICE-scrapped-killing-people.html#ixzz12iTaZcQf (accessed 28 April 2011).